Figure 5. Secondary antigenic challenge increases mDC levels in allogeneic recipients.

Plotted values (mean ± SD) represent average levels of circulating lymphocyte populations for the indicated treatment groups. Values were determined from peripheral blood before secondary antigen challenge (B/CH) and at 7 days post-challenge (P/CH). Pre-challenge baseline values were determined as described in figure 4. *P<0.05, **P<0.01. P values were determined using unpaired, two-tailed Student t Test throughout.